GLENN JEFFREY S has a total of 15 patent applications. Its first patent ever was published in 1992. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, GOVERNMENT OF THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES CT S FOR DISEASE CONTROL AND and CEMM FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Computer technology | |
#6 | Organic fine chemistry | |
#7 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Glenn Jeffrey S | 14 |
#2 | Glass John Irvin | 2 |
#3 | Myers Tina Marie | 2 |
#4 | Cho Nam-Joon | 2 |
#5 | Pang Phillip S | 2 |
#6 | Yang Wenjin | 2 |
#7 | Glenn Jeffrey | 1 |
#8 | Choong Ingrid C | 1 |
#9 | Patel Shripa | 1 |
#10 | Einav Shirit | 1 |
Publication | Filing date | Title |
---|---|---|
US2012148534A1 | Methods and compositions of treating a Flaviviridae family viral infection | |
US2011217265A1 | Screening for Inhibitors of HCV Amphipathic Helix (AH) Function | |
US2009083869A1 | Methods and compositions for identifying agents that inhibit an NS4B-mediated neoplastic cellular phenotype of HCV infected cells | |
US2006248606A1 | Mouse model for hepatitis C | |
US2006040259A1 | Method for inhibition of viral infection | |
US5503973A | Method for inhibition of viral morphogenesis |